Anti-TNF treatment resulted in significantly increased Def6 levels in peripheral blood mononuclear cells (PBMCs) from RA patients, further confirming that TNF downregulates Def6 expression and supporting a role for Def6 in modulating the effects of TNF on osteoclastogenesis. Here, DEF6 is linked to rheumatoid arthritis.